Literature DB >> 24112972

The expanding roles of the Sd(a)/Cad carbohydrate antigen and its cognate glycosyltransferase B4GALNT2.

Fabio Dall'Olio1, Nadia Malagolini, Mariella Chiricolo, Marco Trinchera, Anne Harduin-Lepers.   

Abstract

BACKGROUND: The histo-blood group antigens are carbohydrate structures present in tissues and body fluids, which contribute to the definition of the individual immunophenotype. One of these, the Sd(a) antigen, is expressed on the surface of erythrocytes and in secretions of the vast majority of the Caucasians and other ethnic groups. SCOPE OF REVIEW: We describe the multiple and unsuspected aspects of the biology of the Sd(a) antigen and its biosynthetic enzyme β1,4-N-acetylgalactosaminyltransferase 2 (B4GALNT2) in various physiological and pathological settings. MAJOR
CONCLUSIONS: The immunodominant sugar of the Sd(a) antigen is a β1,4-linked N-acetylgalactosamine (GalNAc). Its cognate glycosyltransferase B4GALNT2 displays a restricted pattern of tissue expression, is regulated by unknown mechanisms - including promoter methylation, and encodes at least two different proteins, one of which with an unconventionally long cytoplasmic portion. In different settings, the Sd(a) antigen plays multiple and unsuspected roles. 1) In colon cancer, its dramatic down-regulation plays a potential role in the overexpression of sialyl Lewis antigens, increasing metastasis formation. 2) It is involved in the lytic function of murine cytotoxic T lymphocytes. 3) It prevents the development of muscular dystrophy in various dystrophic murine models, when overexpressed in muscular fibers. 4) It regulates the circulating half-life of the von Willebrand factor (vWf), determining the onset of a bleeding disorder in a murine model. GENERAL SIGNIFICANCE: The expression of the Sd(a) antigen has a wide impact on the physiology and the pathology of different biological systems.
© 2013.

Entities:  

Keywords:  AchR; B4GALNT1; B4GALNT2; Bleeding disorder; CTL; DAPC; DBA; DMD; Dolichos biflorus agglutinin; Duchenne muscular dystrophy; Epigenetic control; Fuc; Gal; GalNAc; GdA; GdC; GdF; GdS; Glc; GlcNAc; Glycosyltransferase; HPA; Helix pomatia agglutinin; Histo-blood group antigen; Muscular dystrophy; N-CAM; N-acetylgalactosamine; N-acetylglucosamine; N-acetylneuraminic acid; N-glycolylneuraminic acid; NK; Neu5Ac; Neu5Gc; PHA; Sia; Sialyl Lewis antigen; THGP; TLC; Tamm–Horsfall glycoprotein; VVA; Vicia villosa agglutinin; aa; acetylcholine receptor; amino acids; base pairs; bp; cytotoxic T lymphocytes; dystrophin-associated protein complex; fucose; galactose; glucose; glycodelin-A; glycodelin-C; glycodelin-F; glycodelin-S; natural killer cell; neural cell adhesion molecule; nt; nucleotides; phytohaemagglutinin; sLe(a); sLe(x); sialic acid; sialyl Lewis a; sialyl Lewis x; thin layer chromatography; vWf; von Willebrand factor; α-DG; α-dystroglycan; β-1,4-N-acetylgalactosaminyltransferase 1; β-1,4-N-acetylgalactosaminyltransferase 2; β-DG; β-dystroglycan

Mesh:

Substances:

Year:  2013        PMID: 24112972     DOI: 10.1016/j.bbagen.2013.09.036

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  25 in total

Review 1.  Beyond the mouse monopoly: studying the male germ line in domestic animal models.

Authors:  Raquel González; Ina Dobrinski
Journal:  ILAR J       Date:  2015

2.  Induction of T-Cell Infiltration and Programmed Death Ligand 2 Expression by Adeno-Associated Virus in Rhesus Macaque Skeletal Muscle and Modulation by Prednisone.

Authors:  Megan L Cramer; Guohong Shao; Louise R Rodino-Klapac; Louis G Chicoine; Paul T Martin
Journal:  Hum Gene Ther       Date:  2017-03-23       Impact factor: 5.695

3.  A CRISPR Activation Screen Identifies a Pan-avian Influenza Virus Inhibitory Host Factor.

Authors:  Brook E Heaton; Edward M Kennedy; Rebekah E Dumm; Alfred T Harding; Matthew T Sacco; David Sachs; Nicholas S Heaton
Journal:  Cell Rep       Date:  2017-08-15       Impact factor: 9.423

4.  Soluble Heparin Binding Epidermal Growth Factor-Like Growth Factor Is a Regulator of GALGT2 Expression and GALGT2-Dependent Muscle and Neuromuscular Phenotypes.

Authors:  Megan L Cramer; Rui Xu; Paul T Martin
Journal:  Mol Cell Biol       Date:  2019-06-27       Impact factor: 4.272

5.  Carbohydrate antigen expression and anti-pig antibodies in New World capuchin monkeys: Relevance to studies of xenotransplantation.

Authors:  Qi Li; Sahar Shaikh; Hayato Iwase; Cassandra Long; Whayoung Lee; Zhongqiang Zhang; Yi Wang; David Ayares; David K C Cooper; Hidetaka Hara
Journal:  Xenotransplantation       Date:  2019-02-16       Impact factor: 3.907

6.  Intestinal Muc2 mucin O-glycosylation is affected by microbiota and regulated by differential expression of glycosyltranferases.

Authors:  Liisa Arike; Jessica Holmén-Larsson; Gunnar C Hansson
Journal:  Glycobiology       Date:  2017-04-01       Impact factor: 4.313

Review 7.  B4GALNT2 Controls Sda and SLex Antigen Biosynthesis in Healthy and Cancer Human Colon.

Authors:  Sophie Groux-Degroote; Dorothée Vicogne; Virginie Cogez; Céline Schulz; Anne Harduin-Lepers
Journal:  Chembiochem       Date:  2021-09-14       Impact factor: 3.461

8.  B4GALNT2 (GALGT2) Gene Therapy Reduces Skeletal Muscle Pathology in the FKRP P448L Mouse Model of Limb Girdle Muscular Dystrophy 2I.

Authors:  Paul J Thomas; Rui Xu; Paul T Martin
Journal:  Am J Pathol       Date:  2016-09       Impact factor: 4.307

9.  Therapeutic adenoviral gene transfer of a glycosyltransferase for prevention of peritoneal dissemination and metastasis of gastric cancer.

Authors:  Y I Kawamura; Y Adachi; D T Curiel; R Kawashima; R Kannagi; N Nishimoto; T Dohi
Journal:  Cancer Gene Ther       Date:  2014-09-12       Impact factor: 5.987

10.  Expression of the Blood-Group-Related Gene B4galnt2 Alters Susceptibility to Salmonella Infection.

Authors:  Philipp Rausch; Natalie Steck; Abdulhadi Suwandi; Janice A Seidel; Sven Künzel; Kirandeep Bhullar; Marijana Basic; Andre Bleich; Jill M Johnsen; Bruce A Vallance; John F Baines; Guntram A Grassl
Journal:  PLoS Pathog       Date:  2015-07-02       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.